Please join us for our shareholder call Nov. 11 at Noon ET.
The only company to pair AI technology with a database of 150K tumor samples
Tumor-specific in vitro 3D models for drug development
Formulation solutions and endotoxin removal
Helping to discover cancer treatments.
Identifying drugs of interest and accelerating drug discovery.
Uses our exclusive AI platform to compare against patient populations of more than 150K+ tumor samples and maintains active clinical testing in our CLIA certified lab.
Accelerating drug development using 3D models.
Developing tumor-specific in vitro 3D models for drug development.
Utilizes tumor-specific 3D cell culture models, enabling more-successful drug development.
Innovating solutions to improve your biologics' performance.
Providing soluble and stable formulations.
People with passion and purpose.
Meet some of the faces behind Predictive Oncology.
"Who can I help, and how can I help, to ease the burden of those suffering from cancer?"
Chief Executive Officer
& Chairman of the Board
“How can we eliminate cancer and add value to the shareholder along the way?”
Chief Financial Officer Site Leader, Skyline Medical
“How can we guarantee protein stability?”
SVP, Operations, POAI
President, Soluble Biotech
“How can we use AI to personalize cancer therapy?”
SVP, Regulatory Affairs, POAI Quality Site Leader, Helomics
“How can we model tumors outside of the human body?”
Chief Scientific Officer, POAI
“How can the best drug be chosen for development?”
SVP, Strategic Sales and